A steroid produced by the Framingham-based New England Compounding Center has been linked to a fungal meningitis outbreak that’s killed 44. The company filed for Chapter 11 bankruptcy in December, saying the purpose of the filing was to establish a compensation fund for victims.
The company at first opposed an independent trustee, saying it would
delay progress toward establishing the fund. Lawyers on Thursday dropped
objections, saying the company did not want a battle with creditor.
Here is the Order: